US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Emmaus Life Sciences, Inc.

0.0139

-0.0006-4.10%

Volume:117.89K

Turnover:1.68K

Market Cap:975.76K

PE:-0.12

High:0.0146

Open:0.0146

Low:0.0139

Close:0.0145

52wk High:0.0470

52wk Low:0.0080

Shares:70.20M

Float Shares:35.99M

Volume Ratio:16.76

T/O Rate:0.33%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1141

EPS(LYR):-0.0703

ROE:-13.36%

ROA:-1.89%

PB:-0.02

PE(LYR):-0.20

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BRIEF-Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech

Emmaus Life Sciences Inc - Grants Nit Exclusive License to Market, Sell and Distribute Endari in U.S. and Canada

THOMSON REUTERS

Emmaus Life Sciences Inc - Enters License and Distribution Agreement With Neoimmunetech

THOMSON REUTERS

Emmaus Life Sciences Grants NeoImmuneTech Exclusive North American Rights to Endari

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/EMMA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EMMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EMMA\",,,,,undefined,":{"symbol":"EMMA","market":"US","secType":"STK","nameCN":"Emmaus Life Sciences, Inc.","latestPrice":0.0139,"timestamp":1770411600000,"preClose":0.014495,"halted":0,"volume":117890,"delay":15,"changeRate":-0.04104863746119352,"floatShares":35988185,"shares":70198300,"eps":-0.114131,"marketStatus":"Market Closed","change":-0.000595,"latestTime":"02-06 16:00:00 EST Delay","open":0.0146,"high":0.0146,"low":0.0139,"amount":1679.8072,"amplitude":0.048293,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.114131,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"OTCQB","adjPreClose":0.014495,"volumeRatio":16.76097569653121},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EMMA\",,,,,undefined,":{"symbol":"EMMA","floatShares":35988185,"roa":"-1.89%","roe":"-13.36%","lyrEps":-0.070294,"volumeRatio":16.76097569653121,"shares":70198300,"dividePrice":0,"high":0.0146,"amplitude":0.048293,"preClose":0.014495,"low":0.0139,"week52Low":0.008,"pbRate":"-0.02","psRate":"0.08","week52High":0.047,"institutionHeld":0,"latestPrice":0.0139,"eps":-0.114131,"divideRate":0,"volume":117890,"delay":15,"ttmEps":-0.114131,"open":0.0146,"prevYearClose":0.013,"prevWeekClose":0.0139,"prevMonthClose":0.0139,"prevQuarterClose":0.013,"fiveDayClose":0.0139,"twentyDayClose":0.013,"sixtyDayClose":0.0116},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EMMA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-19","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731992400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-11-14","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1668402000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-08-15","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1660536000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2019-11-12","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":-1.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1573534800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2019-08-12","symbol":"EMMA","fiscalQuarterEnding":"2019/06","expectedEps":-1.56,"name":null,"time":"","type":"earning","dateTimestamp":1565582400000,"reportTimeType":"","actualEps":-1.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EMMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EMMA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EMMA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2595661748","title":"BRIEF-Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech","url":"https://stock-news.laohu8.com/highlight/detail?id=2595661748","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595661748?lang=en_us&edition=fundamental","pubTime":"2025-12-31 06:24","pubTimestamp":1767133463,"startTime":"0","endTime":"0","summary":"BRIEF-Emmaus Life Sciences Enters License And Distribution Agreement With NeoimmunetechDec 30 (Reuters) - Neoimmunetech Inc 950220.KQ:EMMAUS LIFE SCIENCES INC - ENTERS LICENSE AND DISTRIBUTION AGREEME","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nFWN3Y00K0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMMA","BK4007"],"gpt_icon":0},{"id":"2595103957","title":"Emmaus Life Sciences Inc - Grants Nit Exclusive License to Market, Sell and Distribute Endari in U.S. and Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2595103957","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595103957?lang=en_us&edition=fundamental","pubTime":"2025-12-31 05:30","pubTimestamp":1767130237,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nFWN3Y00K0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","EMMA"],"gpt_icon":0},{"id":"2595103847","title":"Emmaus Life Sciences Inc - Enters License and Distribution Agreement With Neoimmunetech","url":"https://stock-news.laohu8.com/highlight/detail?id=2595103847","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595103847?lang=en_us&edition=fundamental","pubTime":"2025-12-31 05:30","pubTimestamp":1767130237,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nFWN3Y00K0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","EMMA"],"gpt_icon":0},{"id":"2595471036","title":"Emmaus Life Sciences Grants NeoImmuneTech Exclusive North American Rights to Endari","url":"https://stock-news.laohu8.com/highlight/detail?id=2595471036","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595471036?lang=en_us&edition=fundamental","pubTime":"2025-12-31 05:30","pubTimestamp":1767130216,"startTime":"0","endTime":"0","summary":"Emmaus Life Sciences Inc. announced that it has entered into a License and Exclusive Distribution Agreement with NeoImmuneTech, Inc. Under the terms of the agreement, Emmaus has granted NeoImmuneTech exclusive rights to market, sell, and distribute Endari  and any generic equivalents for the treatment of sickle cell disease in the U.S., its territories, and Canada. The agreement includes an upfront payment to Emmaus and a royalty on product sales by NeoImmuneTech. The effective date of the agreement is contingent upon NeoImmuneTech obtaining the necessary regulatory approvals and licensing to sell and distribute the products, as well as the fulfillment of other specified conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Emmaus","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL3ynWqd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMMA","BK4007"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EMMA\",params:#limit:6,delay:false,,,undefined,":[]}}